Saturday 17 October 2026
Export SBC’s income statement to Excel — free account
SBC Medical Group Holdings Incorporated
SBC Industrials Consulting Services
SBC Medical Group Holdings Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $173.6 million, down 15.5% from fiscal 2024. In the quarter to June 2026, revenue grew 13.4%, EPS grew 400.0%, free cash flow grew 396.1% and total debt rose 420.7%, each against the same quarter a year earlier. Dividend growth for five consecutive years.
5.16
0.14
−2.64%
Follow SBC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
6.55 | 10.72 | 8.80 | 10.59 |
+8 more quarters Free account |
P/S ratio |
1.80 | 2.53 | 2.56 | 2.50 | |
P/FCF ratio |
4.75 | 11.60 | 14.91 | 0.00 | |
P/Operating CF |
14.04 | 46.44 | 8.54 | (21.33) | |
P/B ratio |
1.13 | 1.59 | 1.69 | 1.80 | |
Price to Tangible BV |
1.44 | 2.06 | 2.22 | 2.03 | |
EV/Sales |
0.97 | 1.78 | 1.86 | 1.90 | |
EV/EBITDA |
2.46 | 4.73 | 4.60 | 5.45 | |
EV/Operating CF |
2.69 | 9.44 | 13.08 | (9.81) | |
EV/FCF |
2.55 | 8.16 | 10.84 | (10.02) | |
Quick Ratio |
3.00 | 3.39 | 3.34 | 4.51 | |
Current Ratio |
3.31 | 3.82 | 3.78 | 5.10 | |
Net Debt/EBITDA |
(7.31) | (6.91) | (8.96) | (6.39) | |
Debt/Assets |
9.30% | 10.44% | 11.29% | 6.62% | |
Debt/Equity |
0.14 | 0.15 | 0.16 | 0.09 | |
Asset Turnover |
0.49 | 0.50 | 0.54 | 0.58 | |
Operating CF/Net income |
2.11 | 0.82 | 3.66 | (1.63) | |
Capex/Depreciation |
(0.41) | (0.82) | 5.63 | 1.14 | |
Interest Coverage |
147.44 | 154.36 | 229.04 | 326.77 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
34.60% | 29.32% | 40.64% | 33.98% | |
Intangible Assets out of Total Assets |
0.15 | 0.16 | 0.17 | 0.09 | |
Share Based Compensation of Revenue |
0.02% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
0.42 | 0.28 | 0.26 | 0.35 | |
Graham Number |
5.37 | 4.81 | 5.31 | 4.72 | |
Earnings Yield |
15.26% | 9.33% | 11.37% | 9.45% | |
Free Cash Flow Yield |
21.03% | 8.62% | 6.71% | (7.60%) | |
Revenue per Share |
0.48 | 0.42 | 0.38 | 0.42 | |
Operating CF per Share |
0.22 | 0.09 | 0.50 | (0.20) | |
Capex per Share |
0.00 | (0.01) | 0.04 | 0.01 | |
Free Cash Flow per Share |
0.21 | 0.08 | 0.54 | (0.20) | |
Cash per Share |
1.80 | 1.63 | 1.59 | 1.24 | |
Shareholders Equity per Share |
2.73 | 2.64 | 2.56 | 2.42 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.73 | 2.64 | 2.56 | 2.42 | |
Free Cash Flow |
22.04 | 8.68 | 55.76 | (20.03) | |
Working Capital |
180.93 | 176.21 | 170.10 | 182.62 | |
Capital Expenditures |
(0.46) | (0.55) | 3.80 | 0.85 | |
Net Current Asset Value |
132.64 | 121.14 | 114.08 | 153.90 | |
EV/EBIT |
2.59 | 4.95 | 4.78 | 5.72 | |
Capex to Sales |
0.01 | 0.01 | (0.10) | (0.02) | |
Price to Operating Income |
4.83 | 7.03 | 6.58 | 7.51 | |
| Other line items | |||||
Average Receivables |
57.27 | 42.85 | 40.21 | 59.77 | |
Average Payables |
21.65 | 19.35 | 16.09 | 17.49 | |
Average Inventory |
2.34 | 2.01 | 2.14 | 1.83 | |
Average Assets |
360.98 | 336.31 | 323.27 | 308.92 | |
Average Common Equity |
262.28 | 248.35 | 229.16 | 226.79 |
Columns are period end dates